6 research outputs found
Insulin Promoter-Driven <i>Gaussia</i> Luciferase-Based Insulin Secretion Biosensor Assay for Discovery of β‑Cell Glucose-Sensing Pathways
High
throughput screening of insulin secretion is intractable with
current methods. We developed a secreted insulin–luciferase
system (Ins-GLuc) in β cells that is rapid, inexpensive, and
amenable to 96- and 384-well formats. We treated stable Ins-GLuc-expressing
MIN6 cells overnight with 6298 marine natural product fractions. The
cells were then washed to remove media and chemicals, followed by
stimulation with glucose in the diazoxide paradigm. These conditions
allowed the discovery of many insulin secretion suppressors and potentiators.
The mechanisms of action of these natural products must be long-lasting
given the continuance of secretory phenotypes in the absence of chemical
treatment. We anticipate that these natural products and their target
pathways will lead to a greater understanding of glucose-stimulated
insulin secretion
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β‑Cells
Novel strategies are needed to modulate
β-cell differentiation
and function as potential β-cell replacement or restorative
therapies for diabetes. We previously demonstrated that small molecules
based on the isoxazole scaffold drive neuroendocrine phenotypes. The
nature of the effects of isoxazole compounds on β-cells was
incompletely defined. We find that isoxazole induces genes that support
neuroendocrine and β-cell phenotypes and suppresses genes important
for proliferation. Isoxazole alters β-cell metabolites and protects
glucose-responsive signaling pathways under lipotoxic conditions.
Finally, we show that isoxazole improves glycemia in a mouse model
of β-cell regeneration. Isoxazole is a prime candidate to alter
cell fate in different contexts
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β‑Cells
Novel strategies are needed to modulate
β-cell differentiation
and function as potential β-cell replacement or restorative
therapies for diabetes. We previously demonstrated that small molecules
based on the isoxazole scaffold drive neuroendocrine phenotypes. The
nature of the effects of isoxazole compounds on β-cells was
incompletely defined. We find that isoxazole induces genes that support
neuroendocrine and β-cell phenotypes and suppresses genes important
for proliferation. Isoxazole alters β-cell metabolites and protects
glucose-responsive signaling pathways under lipotoxic conditions.
Finally, we show that isoxazole improves glycemia in a mouse model
of β-cell regeneration. Isoxazole is a prime candidate to alter
cell fate in different contexts
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β‑Cells
Novel strategies are needed to modulate
β-cell differentiation
and function as potential β-cell replacement or restorative
therapies for diabetes. We previously demonstrated that small molecules
based on the isoxazole scaffold drive neuroendocrine phenotypes. The
nature of the effects of isoxazole compounds on β-cells was
incompletely defined. We find that isoxazole induces genes that support
neuroendocrine and β-cell phenotypes and suppresses genes important
for proliferation. Isoxazole alters β-cell metabolites and protects
glucose-responsive signaling pathways under lipotoxic conditions.
Finally, we show that isoxazole improves glycemia in a mouse model
of β-cell regeneration. Isoxazole is a prime candidate to alter
cell fate in different contexts
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β‑Cells
Novel strategies are needed to modulate
β-cell differentiation
and function as potential β-cell replacement or restorative
therapies for diabetes. We previously demonstrated that small molecules
based on the isoxazole scaffold drive neuroendocrine phenotypes. The
nature of the effects of isoxazole compounds on β-cells was
incompletely defined. We find that isoxazole induces genes that support
neuroendocrine and β-cell phenotypes and suppresses genes important
for proliferation. Isoxazole alters β-cell metabolites and protects
glucose-responsive signaling pathways under lipotoxic conditions.
Finally, we show that isoxazole improves glycemia in a mouse model
of β-cell regeneration. Isoxazole is a prime candidate to alter
cell fate in different contexts
Isoxazole Alters Metabolites and Gene Expression, Decreasing Proliferation and Promoting a Neuroendocrine Phenotype in β‑Cells
Novel strategies are needed to modulate
β-cell differentiation
and function as potential β-cell replacement or restorative
therapies for diabetes. We previously demonstrated that small molecules
based on the isoxazole scaffold drive neuroendocrine phenotypes. The
nature of the effects of isoxazole compounds on β-cells was
incompletely defined. We find that isoxazole induces genes that support
neuroendocrine and β-cell phenotypes and suppresses genes important
for proliferation. Isoxazole alters β-cell metabolites and protects
glucose-responsive signaling pathways under lipotoxic conditions.
Finally, we show that isoxazole improves glycemia in a mouse model
of β-cell regeneration. Isoxazole is a prime candidate to alter
cell fate in different contexts